Current developments and future perspectives for TB diagnostics

Future Microbiology

Volumn 7, Issue 1, 2012, Pages 59-71

  Palomino, Juan Carlos ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

colorimetric methods; diagnostics; molecular detection; Mycobacterium tuberculosis; rapid tests; TB

Indexed keywords

AMIKACIN; CAPREOMYCIN; ETHAMBUTOL; GENOMIC DNA; GREEN FLUORESCENT PROTEIN; ISONIAZID; PYROPHOSPHATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RESAZURIN; STREPTOMYCIN; TETRAZOLIUM;

AMPLICON; AMPLICOR MYCOBACTERIUM TUBERCULOSIS TEST; ANOREXIA; ASSAY; BACILLACEAE; BACTERIUM ISOLATION; CHILL; COLORIMETRY; COUGHING; CULTURE TECHNIQUE; DIAGNOSTIC PROCEDURE; DNA DETERMINATION; DNA EXTRACTION; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRAPULMONARY TUBERCULOSIS; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPE; FLUORESCENCE MICROSCOPY; HUMAN; IN VITRO STUDY; LINE PROBE ASSAY; LUNG TUBERCULOSIS; META ANALYSIS (TOPIC); MICROSCOPY; MOLECULAR DIAGNOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; SEDIMENTATION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; SPUTUM SMEAR; STAINING; SWEAT; SYSTEMATIC REVIEW (TOPIC); T LYMPHOCYTE; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; WEIGHT REDUCTION;

DIAGNOSTIC TECHNIQUES AND PROCEDURES; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84555202679     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.133     Document Type: Review

References (104)

1. WHO. Towards Universal Access to Diagnosis and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis by 2015. WHO Progress Report 2011. WHO, Geneva, Switzerland (2011).
2. Wells CD, Cegielski JP, Nelson LJ et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J. Infect. Dis. 196(Suppl. 1), S86-S107 (2007). (Pubitemid 47206088)
3. Sester M, Giehl C, McNerney R et al. Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection. Eur. Respir. J. 36, 1242-1247 (2010).
4. th Edition The Essentials. Raviglione M (Ed.). Informa Healthcare, NY, USA, 81-112 (2010).
5. Yeager H Jr, Lacy J, Smith LR, LeMaistre CA. Quantitative studies of mycobacterial populations in sputum and saliva. Am. Rev. Respir. Dis. 95, 998-1004 (1967).
6. Ganoza CA, Ricaldi JN, Chauca J et al. Novel hypertonic saline-sodium hydroxide (HS-SH) method for decontamination and concentration of sputum samples for Mycobacterium tuberculosis microscopy and culture. J. Med. Microbiol. 57(Pt 9), 1094-1098 (2008).
7. Angeby KA, Hoffner SE, Diwan VK. Should the 'bleach microscopy method' be recommended for improved case detection of tuberculosis? Literature review and key person ana lysis. Int. J. Tuberc. Lung Dis. 8(7), 806-815 (2004). (Pubitemid 38937596)
8. Steingart KR, Ng V, Henry M et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect. Dis. 6(10), 664-674 (2006). (Pubitemid 44462695)
9. Schunemann HJ, Oxman AD, Brozek J et al. GRADE: assessing the quality of evidence for diagnostic recommendations. Evid. Based Med. 13, 162-163 (2008).
10. Cattamanchi A, Davis JL, Pai M et al. Does bleach processing increase the accuracy of sputum smear microscopy for diagnosing pulmonary tuberculosis? J. Clin. Microbiol. 48(7), 2433-2439 (2010).
11. Annam V, Kulkarni MH, Puranik RB. Comparison of the modifed fuorescent method and conventional Ziehl-Neelsen method in the detection of acidfast bacilli in lymphnode aspirates. Cytojournal 6, 13 (2009).
12. Lehman LG, Ngapmen Yamadji AL, Ngo Sack F et al. The CyScope® fuorescence microscope, a reliable tool for tuberculosis diagnosis in resource-limited settings. Am. J. Trop. Med. Hyg. 83(4), 906-908 (2010).
13. Palomino JC. Newer diagnostics for tuberculosis and multi-drug resistant tuberculosis. Curr. Opin. Pulm. Med. 12(3), 172-178 (2006). (Pubitemid 44350471)
14. Palomino JC, Martin A, Von Groll A et al. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis. J. Microbiol. Methods 75(2), 161-166 (2008).
15. Rodrigues C, Shenai S, Sadani M et al. Evaluation of the Bactec MGIT 960 TB system for recovery and identifcation of Mycobacterium tuberculosis complex in a high through put tertiary care centre. Indian J. Med. Microbiol. 27(3), 217-221 (2009).
16. Lin SY, Desmond E, Bonato D et al. Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex. J. Clin. Microbiol. 47(11), 3630-3634 (2009).
17. Van Deun A, Martin A, Palomino JC. Diagnosis of drug-resistant tuberculosis: reliability and rapidity of detection. Int. J. Tuberc. Lung Dis. 14(2), 131-140 (2010).
18. Martin A, Bombeeck D, Fissette K et al. Evaluation of the BD MGIT TBc Identifcation Test (TBc ID), a rapid chromatographic immunoassay for the detection of Mycobacterium tuberculosis complex from liquid culture. J. Microbiol. Methods 84(2), 255-257 (2011).
19. Sharma B, Pal N, Malhotra Bet al. Evaluation of a Rapid Differentiation Test for Mycobacterium tuberculosis from other Mycobacteria by Selective Inhibition with p-nitrobenzoic Acid using MGIT 960. J. Lab. Physicians 2(2), 89-92 (2010).
20. Shen GH, Chen CH, Hung CH et al. Combining the Capilia TB assay with smear morphology for the identifcation of Mycobacterium tuberculosis complex. Int. J. Tuberc. Lung Dis. 13(3), 371-366 (2009).
21. Biswas D, Deb A, Gupta P et al. Evaluation of the usefulness of phage amplifcation technology in the diagnosis of patients with paucibacillary tuberculosis. Indian J. Med. Microbiol. 26(1), 75-78 (2008). (Pubitemid 351197569)
22. Mole R, Trollip A, Abrahams C et al. Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis. J. Med. Microbiol. 56(Pt 10), 1334-1339 (2007). (Pubitemid 350105601)
23. Piuri M, Jacobs WR Jr, Hatfull GF. Fluoromycobacteriophages for rapid, specifc, and sensitive antibiotic susceptibility testing of Mycobacterium tuberculosis. PLoS ONE 4(3), E4870 (2009).
24. Rondón L, Piuri M, Jacobs WR Jr et al. Evaluation of Fluoromycobacteriophages for detecting drug resistance in Mycobacterium tuberculosis. J. Clin. Microbiol. 49, 1838-1842 (2011).
25. Robledo JA, Mejía GI, Morcillo N et al. Evaluation of a rapid culture method for tuberculosis diagnosis: a Latin American multi-center study. Int. J. Tuberc. Lung Dis. 10(6), 613-619 (2006). (Pubitemid 43845021)
26. Moore DA, Evans CA, Gilman RH et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N. Engl. J. Med. 355(15), 1539-1550 (2006). (Pubitemid 44547806)
27. Limaye K, Kanade S, Nataraj G et al. Utility of Microscopic Observation of Drug Susceptibility (MODS) assay for Mycobacterium tuberculosis in resource constrained settings. Indian J. Tuberc. 57(4), 207-212 (2010).
28. Martin A, Munga Waweru P, Babu Okatch F et al. Implementation of the thin layer agar method for diagnosis of smear-negative pulmonary tuberculosis in a setting with a high prevalence of human immunodefciency virus infection in Homa Bay, Kenya. J. Clin. Microbiol. 47(8), 2632-2634 (2009).
29. Minion J, Leung E, Menzies D et al. Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-ana lysis. Lancet Infect. Dis. 10(10), 688-698 (2010).
30. Palomino JC, Martin A, Portaels F. Rapid drug resistance detection in Mycobacterium tuberculosis: a review of colorimetric methods. Clin. Microbiol. Infect. 13(8), 754-762 (2007). (Pubitemid 47039907)
31. Martin A, Morcillo N, Lemus D et al. Multicenter study of MTT and resazurin assays for testing susceptibility to frst-line anti-tuberculosis drugs. Int. J. Tuberc. Lung Dis. 9(8), 901-906 (2005). (Pubitemid 41139650)
32. Montoro E, Lemus D, Echemendia M et al. Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 55(4), 500-505 (2005). (Pubitemid 40542590)
33. Shikama M de L, Silva RR, Martins MC et al. Rapid detection of resistant tuberculosis by nitrate reductase assay performed in three settings in Brazil. J. Antimicrob. Chemother. 64(4), 794-796 (2009).
34. Affolabi D, Odoun M, Sanoussi N et al. Rapid and inexpensive detection of multidrug-resistant Mycobacterium tuberculosis with the nitrate reductase assay using liquid medium and direct application to sputum samples. J. Clin. Microbiol. 46(10), 3243-3425 (2008).
35. Martin A, Portaels F, Palomino JC. Colorimetric redox-indicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-ana lysis. J. Antimicrob. Chemother. 59(2), 175-183 (2007). (Pubitemid 47072054)
36. Martin A, Panaiotov S, Portaels F et al. The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-ana lysis. J. Antimicrob. Chemother. 62(1), 56-64 (2008). (Pubitemid 351865874)
37. Shamputa IC, Rigouts L, Portaels F. Molecular genetic methods for diagnosis and antibiotic resistance detection of mycobacteria from clinical specimens. APMIS 112, 728-752 (2004).
38. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev. Mol. Diagn. 6, 423-432(2006). (Pubitemid 44174346)
39. Sperhacke RD, Mello FC, Zaha A. Detection of Mycobacterium tuberculosis by a polymerase chain reaction colorimetric dot-blot assay. Int. J. Tuberc. Lung Dis. 8, 312-317 (2004). (Pubitemid 38624868)
40. Chakravorty S, Dudeja M, Hanif M et al. Utility of universal sample processing methodology, combining smear microscopy, culture, and PCR, for diagnosis of pulmonary tuberculosis. J. Clin. Microbiol. 43(6), 2703-2708 (2005). (Pubitemid 40827942)
41. Greco S, Rulli M, Girardi E et al. Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: meta-ana lysis and metaregression. J. Clin. Microbiol. 47(3), 569-576 (2009).
42. Flores LL, Pai M, Colford JM Jr et al. In-house nucleic acid amplifcation tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-ana lysis and meta-regression. BMC Microbiol. 5, 55 (2005).
43. Palomino JC. Molecular detection, identifcation and drug resistance detection in Mycobacterium tuberculosis. FEMS Immunol. Med. Microbiol. 56(2), 103-111 (2009).
44. Michos AG, Daikos GL, Tzanetou K et al. First detection of Mycobacterium tuberculosis DNA in respiratory and non-respiratory specimens by the Amplicor MTB PCR. Diagn. Microbiol. Infect. Dis. 54, 121-126 (2006). (Pubitemid 43176601)
45. Ozkutuk A, Kirdar S, Ozden S et al. Evaluation of Cobas Amplicor MTB test to detect Mycobacterium tuberculosis in pulmonary and extrapulmonary specimens. New Microbiol. 29, 269-273 (2006). (Pubitemid 44968368)
46. Abe C, Hirano K, Wada Met al. Detection of Mycobacterium tuberculosis in clinical specimens by polymerase chain reaction and Gen-Probe Amplifed Mycobacterium Tuberculosis Direct Test. J. Clin. Microbiol. 31, 3270-3274 (1993). (Pubitemid 23335621)
47. Coll P, Garrigo M, Moreno C et al. Routine use of Gen-probe Amplifed Mycobacterium Tuberculosis Direct (MTD) test for detection of Mycobacterium tuberculosis withsmear-positive and smear-negative specimens. Int. J. Tuberc. Lung Dis. 7, 886-891 (2003). (Pubitemid 37158429)
48. Rusch-Gerdes S, Richter E. Clinical evaluation of thesemi-automated BDProbeTec ET System for the detection of Mycobacterium tuberculosis in respiratory and non-respiratory specimens. Diagn. Microb. Infect. Dis. 48, 265-270 (2004). (Pubitemid 38519584)
49. Mori Y, Nagamine K, Tomita N et al. Detection of loop-mediated isothermal amplifcation reaction by turbidity derived from magnesium pyrophosphate formation. Biochem. Bioph. Res. Com. 289, 150-154 (2001). (Pubitemid 33108807)
50. Iwamoto T, Sonobe T, Hayashi K. Loop-mediated isothermal amplifcation for direct detection of Mycobacterium tuberculosis complex, M. avium, and M. intracellulare insputum samples. J. Clin. Microbiol. 41, 2616-2622 (2003). (Pubitemid 36712475)
51. Boehme CC, Nabeta P, Henostroza G et al. Operational feasibility of using loop-mediated isothermal amplifcation (LAMP) for the diagnosis of pulmonary TB in microscopy centers of developing countries. J. Clin. Microbiol. 45, 1936-1940 (2007). (Pubitemid 46933929)
52. Pandey BD, Poudel A, Yoda T et al. Development of an in-house loop-mediated isothermal amplifcation (LAMP) assay for detection of Mycobacterium tuberculosis and evaluation insputum samples of Nepalese patients. J. Med. Microbiol. 57, 439-443 (2008). (Pubitemid 351537017)
53. Goto M, Honda E, Ogura A et al. Colorimetric detection of loop-mediated isothermal amplifcation reaction by using hydroxynaphthol blue. Biotechniques 46(3), 167-172 (2009).
54. Ling DI, Flores LL, Riley LW et al. Commercial nucleic-acid amplifcation tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-ana lysis and meta-regression. PLoS ONE 2, E1536 (2008).
55. Almeida da Silva PE, Palomino JC. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J. Antimicrob. Chemother. 66(7), 1417-1430 (2011).
56. Garcia de Viedma D. Rapid detection of resistance in Mycobacterium tuberculosis: a review discussing molecularapproaches. Clin. Microbiol. Infect. 9, 349-359 (2003).
57. De Beenhouwer H, Lhiang Z, Jannes G et al. Rapid detection of rifampicin resistance in sputum and biopsy specimens from tuberculosis patients by PCR and line probe assay. Tubercle Lung Dis. 76, 425-430 (1995).
58. Traore H, van Deun A, Shamputa IC et al. Direct detection of Mycobacterium tuberculosis complex DNA and rifampin resistance in clinical specimens from tuberculosis patients by line probe assay. J. Clin. Microbiol. 44, 4384-4388 (2006). (Pubitemid 44937068)
59. Tortoli E, Marcelli F. Use of the INNO LiPARif.TB for detection of Mycobacterium tuberculosis DNA directly in clinical specimens and for simultaneous determination of rifampin susceptibility. Eur. J. Clin. Microbiol. Infect. Dis. 26(1), 51-55 (2007). (Pubitemid 46089582)
60. Morgan M, Kalantri S, Flores L et al. A commercial lineprobe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-ana lysis. BMC Infect. Dis. 5, 62 (2005).
61. Hillemann D, Rusch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45, 2635-2640 (2007). (Pubitemid 47295497)
62. Makinen J, Marttila HJ, Marjamaki M et al. Comparison of two commercially available DNA lineprobe assays for detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 44, 350-352 (2006). (Pubitemid 43222221)
63. Barnard M, Albert H, Coetzee G et al. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Resp. Crit. Care Med. 177, 787-792 (2008). (Pubitemid 351490566)
64. Hillemann D, Rüsch-Gerdes S, Richter E. Feasibility of the GenoTypeMTBDRsl assay for fuoroquinolone, amikacin-capreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 47(6), 1767-1772 (2009).
65. Brossier F, Veziris N, Aubry A et al. Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J. Clin. Microbiol. 48(5), 1683-1689 (2010).
66. Bang H, Park S, Hwang J. Improved rapid molecular diagnosis of multidrug-resistant tuberculosis using a new reverse hybridization assay, REBA MTB-MDR. J. Med. Microbiol. 60(Pt 10), 1447-1454 (2011).
67. Hernández-Neuta I, Varela A, Martin A. Rifampin-isoniazid oligonucleotide typing: an alternative format for rapid detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 48, 4386-4391 (2010).
68. Varma-Basil M, El-Hajj H, Colangeli R et al. Rapid detection of rifampin resistance in Mycobacterium tuberculosis isolates from India and Mexico by a molecular beacon assay. J. Clin. Microbiol. 42, 5512-5516 (2004). (Pubitemid 39664329)
69. Espasa M, Gonzalez-Martin J, Alcaide F et al. Direct detection in clinical samples of multiple gene mutationscausing resistance of Mycobacterium tuberculosis to isoniazidand rifampicin using fuorogenic probes. J. Antimicrob. Chemoth. 55, 860-865 (2005). (Pubitemid 40883168)
70. Saribas Z, Yurdakul P, Alp A, Gunalp A. Use offuorescence resonance energy transfer for rapid detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates. Int. J. Tuberc. Lung Dis. 2, 181-187 (2005). (Pubitemid 40278381)
71. Kim K, Lee H, Lee MK et al. Development and application of multiprobe real-time PCR method targeting the hsp65 gene for differentiation of Mycobacterium species from isolates and sputum specimens. J. Clin. Microbiol. 48(9), 3073-3080 (2010).
72. Raja S, Ching J, Xi L et al. Technology for automated, rapid, and quantitative PCR or reverse transcription-PCR clinical testing. Clin. Chem. 51, 882-890 (2005). (Pubitemid 40577926)
73. Helb D, Jones M, Story E et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J. Clin. Microbiol. 48(1), 229-237 (2010).
74. Lawn SD, Nicol MP. Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 6(9), 1067-1082 (2011).
75. Cobelens FG, Egwaga SM, van Ginkel T et al. Tuberculin skin testing in patients with HIV infection: limited beneft of reduced cut-off values. Clin. Infect. Dis. 43(5), 634-639 (2006). (Pubitemid 44267127)
76. Farhat M, Greenaway C, Pai M et al. False-positive tuberculin skin tests: what is the absolute effect ofBCG and non-tuberculous mycobacteria? Int. J. Tuberc. Lung Dis. 10, 1192-1204 (2006). (Pubitemid 44713473)
77. Pai M, Riley LW, Colford JM Jr. Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect. Dis. 4, 761-776 (2004).
78. Dinnes J, Deeks J, Kunst H et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol. Assess. 11(3), 1-196 (2007).
79. Lalvani A, Pareek M. Interferon gamma release assays: principles and practice. Enferm. Infec. Microbiol. Clin. 28(4), 245-252 (2010).
80. Lee JE, Kim HJ, Lee SW. The clinical utility of tuberculin skin test and interferon-gamma release assay in the diagnosis of active tuberculosis among young adults: a prospective observational study. BMC Infect. Dis. 11(1), 96 (2011).
81. Leung EC, Leung CC, Leung WW et al. Role of whole-blood interferon-gamma release assay in the diagnosis of smearnegative tuberculosis. Int. J. Tuberc. Lung Dis. 14(12), 1564-1570 (2010).
82. Pai M, Zwerling A, Menzies D. Systematic review: T-cell based assays for the diagnosis of latent tuberculosis infection-an update. Ann. Intern. Med. 149, 177-184 (2008).
83. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaana lysis. Chest 137, 952-968 (2010).
84. Onyebujoh P, Rook GAW. Tuberculosis. Nat. Rev. Microbiol. 2, 930-932 (2004). (Pubitemid 39562531)
85. Steingart KR, Henry M, Laal S et al. A systematic review of commercial serological antibody detection tests for the diagnosis of extra-pulmonary tuberculosis. Thorax 62(10), 911-918 (2007). (Pubitemid 47598357)
86. Morris K. WHO recommends against inaccurate tuberculosis tests. Lancet 377(9760), 113-114 (2011).
87. Kunnath-Velayudhan S, Salamon H, Wang HY. Dynamic antibody responses to the Mycobacteriumtuberculosis proteome. Proc. Natl Acad. Sci. 107(33), 14703-14708 (2011).
88. Raqib R, Kamal SM, Rahman MJ et al. Use ofantibodies in lymphocyte secretions for detection of subclinical tuberculosis infection in asymptomatic contacts. Clin. Diagn. Lab. Immunol. 11, 1022-1027 (2004). (Pubitemid 39540838)
89. Raqib R, Mondal D, Karim MA et al. Detection of antibodies secreted from circulating Mycobacterium tuberculosis specifc plasma cells in the diagnosis of pediatric tuberculosis. Clin. Vaccine Immunol. 16, 521-527 (2009).
90. Rekha RS, Kamal SM, Andersen P et al. Validation of the ALS assay in adult patients with culture confrmed pulmonary tuberculosis. PLoS ONE 6(1), E16425 (2011).
91. Fend R, Kolk RH, Bessant C et al. Prospects for clinical application ofelectronic-nose technology to early detection of Mycobacterium tuberculosis in culture and sputum. J. Clin. Microbiol. 44, 2039-2045 (2006). (Pubitemid 43902150)
92. Kolk A, Hoelscher M, Maboko L et al. Electronic-nose technology using sputum samples in diagnosis of patients with tuberculosis. J. Clin. Microbiol. 48(11), 4235-4238 (2010).
93. Kaal E, Kolk AH, Kuijper S et al. A fast method for the identifcation of Mycobacterium tuberculosis in sputum and cultures based on thermally assisted hydrolysis and methylation followed by gas chromatography-mass spectrometry. J. Chromatogr. A. 1216(35), 6319-6325 (2009).
94. Weetjens BJ, Mgode GF, Machang'u RS et al. African pouched rats for the detection of pulmonary tuberculosis in sputum samples. Int. J. Tuberc. Lung Dis. 13(6), 737-743 (2009).
95. Poling A, Weetjens BJ, Cox C et al. Using giant African pouched rats to detect tuberculosis in human sputum samples: 2009 fndings. Am. J. Trop. Med. Hyg 83(6), 1308-1310 (2010).
96. Lee H, Yoon TJ, Weissleder R. Ultrasensitive detection of bacteria using core-shell nanoparticles and an NMR-flter system. Angew. Chem. Int. Ed. Engl. 48(31), 5657-5660 (2009).
97. Lee H, Sun E, Ham D. Chip-NMR biosensor for detection and molecular ana lysis of cells. Nat. Med. 14(8), 869-874 (2008).
98. Lee WG, Kim YG, Chung BG. Nano/microfuidics for diagnosis of infectious diseases in developing countries. Adv. Drug Deliv. Rev. 62(4-5), 449-457 (2010).
99. Hauck TS, Giri S, Gao Y. Nanotechnology diagnostics for infectious diseases prevalent in developing countries. Adv. Drug Deliv. Rev. 62(4-5), 438-448 (2010).
100. Qin D, He X, Wang K et al. Using fuorescent nanoparticles and SYBR Green I based two-color fow cytometry to determine Mycobacterium tuberculosis avoiding false positives. Biosens. Bioelectron. 24(4), 626-631 (2008).
101. Veigas B, Machado D, Perdigão J et al. Au-nanoprobes for detection of SNPs associated with antibiotic resistance in Mycobacterium tuberculosis. Nanotechnology 21(41), 415101 (2010).
102. Frahm M, Goswami MD, Owzar K. Discriminating between active and latent tuberculosis with multiple biomarker responses. Tuberculosis (Edinb.) 91(3), 250-256 (2011).
103. Berry MP, Graham CM, McNab FW An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466(7309), 973-977 (2010).
104. McNerney R, Daley P. Towards a point-of-care test for active tuberculosis: obstacles and opportunities. Nat. Rev. Microbiol. 9(3), 204-213 (2011).